Medical Countermeasures W.H.O. Partner Program Allocates 238,000 Doses of Mpox Vaccine to Four CountriesGlobal Biodefense StaffMarch 19, 2025
Medical Countermeasures Emergent BioSolutions Secures $27 Million in International Orders for Critical Medical CountermeasuresGlobal Biodefense StaffMarch 18, 2025
Medical Countermeasures Tecovirimat Shown to Lack Efficacy as Treatment for Clade II MpoxGlobal Biodefense StaffMarch 12, 2025
MGB Biopharma Receives 6.4M to Advance Novel Antibacterial Antimicrobial Resistance September 18, 2014 …
Antimicrobial Strategy Silences Resistant Gene in Pathogens Antimicrobial Resistance September 8, 2014 …
